Given the relatively small size of this study and the lack of an investigational agent, there will not be a data and safety monitoring committee set up for the purpose of evaluating data and safety of the participants. The principal investigator, as well as the Partners IRB, shall provide oversight and review of the study protocol throughout the duration of the study.